[Non-inferiority and equivalence trials: Key methodological issues]

Area of Science:

• Clinical Trials Methodology
• Pharmaceutical Research
• Medical Treatment Evaluation

Background:

• New treatments may not be superior but offer other benefits (e.g., safety).
• Non-inferiority and equivalence trials are designed for such scenarios.
• These trial types differ methodologically from superiority trials.

Purpose of the Study:

• To explain the methodology of non-inferiority and equivalence trials.
• To highlight critical issues and decision points in these trial designs.
• To inform readers about the nuances of these important clinical trial types.

Main Methods:

• Presentation of general methodology: hypotheses, decision rules, sample size, and analysis.
• Use of examples and graphic illustrations for clarity.
• Identification and discussion of key issues, including comparator and non-inferiority margin selection.

Main Results:

• The article provides a comprehensive overview of non-inferiority and equivalence trial design.
• It elucidates the statistical and practical considerations for conducting and interpreting these trials.
• Key challenges, such as selecting appropriate comparators and defining non-inferiority margins, are addressed.

Conclusions:

• A clear understanding of non-inferiority and equivalence trial methodology is essential.
• Careful consideration of the comparator and non-inferiority margin is critical for trial validity.
• These trials play a vital role in introducing new treatments with added benefits.